MMRV vaccine
The MMRV vaccine combines the attenuated virus MMR (measles, mumps, rubella) vaccine with the addition of the chickenpox vaccine or varicella vaccine (V stands for varicella). The MMRV vaccine is typically given to children between one and two years of age.

Several companies supply MMRV vaccines. ProQuad is marketed by Merck and was approved in 2005, for use in the United States by the Food and Drug Administration (FDA) for children ages twelve months through twelve years. An MMRV vaccine called Priorix Tetra by GlaxoSmithKline has been approved in Germany and Australia.
Q1810913
attenuated virus
Concept
Q908104
MMR
Concept
Q79793
measles
Concept
Q176741
mumps
Concept
Q155857
rubella
Concept
Q44727
chickenpox
Concept
Q2721987
vaccine
Concept
Q44727
varicella
Concept
Q247489
Merck
ORG
Q204711
Food and Drug Administration
Concept
Q212322
GlaxoSmithKline
ORG
Q6716846
MMRV vaccine
Concept
Q6716846
MMRV vaccine
Concept
Q6716846
MMRV vaccine
Concept
Q6716846
MMRV vaccine
Concept
2005-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2005
DATE
subclass of
medical condition treated
subclass of
part of